Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables. 1997

H Suzuki, and S Abo, and M Kitamura, and M Hashimoto, and K Izumi, and K Terada, and T Sugiyama
Second Department of Surgery, Akita University School of Medicine, Japan.

Gene amplification is a relatively frequent event in human malignant tumors and is believed to play an important role in tumor progression. The int-2 and erbB genes are amplified more frequently than any other genes in human esophageal cancer. In order to investigate the correlation between these two proto-oncogenes and the clinical behavior of esophageal cancer, we examined DNA amplification of int-2 and erbB and analyzed their relationship to clinicopathological variables. Genomic DNA was extracted from 21 esophageal squamous carcinomas and normal esophageal mucosa, as well as from 4 metastatic tumors. We used Southern blot analysis for detection of gene amplification. Amplification of int-2 was observed in 13 of 21 cases (62%) and in all the metastatic tumors (4/4; 100%). We found a significant correlation between amplification of int-2 and the length of the primary lesion. Amplification of erbB was detected in 3 of 18 patients (17%). All patients who showed amplification of erbB also demonstrated amplification of int-2. These results suggest that amplification of int-2 or neighboring genes on 11q may participate in tumor progression and metastasis in patients with esophageal squamous cancer.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus

Related Publications

H Suzuki, and S Abo, and M Kitamura, and M Hashimoto, and K Izumi, and K Terada, and T Sugiyama
December 1992, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
H Suzuki, and S Abo, and M Kitamura, and M Hashimoto, and K Izumi, and K Terada, and T Sugiyama
March 1993, International journal of cancer,
H Suzuki, and S Abo, and M Kitamura, and M Hashimoto, and K Izumi, and K Terada, and T Sugiyama
July 2000, International journal of oncology,
H Suzuki, and S Abo, and M Kitamura, and M Hashimoto, and K Izumi, and K Terada, and T Sugiyama
September 1996, The Annals of thoracic surgery,
H Suzuki, and S Abo, and M Kitamura, and M Hashimoto, and K Izumi, and K Terada, and T Sugiyama
January 1996, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
H Suzuki, and S Abo, and M Kitamura, and M Hashimoto, and K Izumi, and K Terada, and T Sugiyama
October 1993, Cancer,
H Suzuki, and S Abo, and M Kitamura, and M Hashimoto, and K Izumi, and K Terada, and T Sugiyama
January 1993, Acta oncologica (Stockholm, Sweden),
H Suzuki, and S Abo, and M Kitamura, and M Hashimoto, and K Izumi, and K Terada, and T Sugiyama
May 1993, Cancer research,
H Suzuki, and S Abo, and M Kitamura, and M Hashimoto, and K Izumi, and K Terada, and T Sugiyama
January 1997, Anticancer research,
H Suzuki, and S Abo, and M Kitamura, and M Hashimoto, and K Izumi, and K Terada, and T Sugiyama
April 1991, Cancer research,
Copied contents to your clipboard!